NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Oral Antivirals for High-Risk COVID-19 Patients

COVID-19 Outpatient Therapeutics

Hydroxychloroquine with or without azithromycin for treatment of

Therapeutic dilemmas in addressing SARS-CoV-2 infection

Phase III Trial to Study Combination of Genentech's Actemra

COVID-19 in people with rheumatic diseases: risks, outcomes

NIH to evaluate remdesivir treatment for COVID during pregnancy

Clinical outcomes of hospitalized COVID-19 patients treated with

Remdesivir: A beacon of hope from Ebola virus disease to COVID‐19

Diagnosis and management of covid-19 in pregnancy

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid

Real-life comparison of mortality in patients with SARS-CoV-2

Facebook Post Misleads on NIH's Position on Ivermectin